MONTELUKAST IN TREATING ALLERGIC DISEASES
Anti inflammatory medications are the basis for pathogenetic treatment of allergic diseases. The review covers description of the most studied and efficient medication of leukotriene receptors' antagonist category montelukast. Specific and reversible antagonism to leukotriene receptors sets two...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2006-08-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/579 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839587228522643456 |
|---|---|
| author | T.V. Kulichenko |
| author_facet | T.V. Kulichenko |
| author_sort | T.V. Kulichenko |
| collection | DOAJ |
| description | Anti inflammatory medications are the basis for pathogenetic treatment of allergic diseases. The review covers description of the most studied and efficient medication of leukotriene receptors' antagonist category montelukast. Specific and reversible antagonism to leukotriene receptors sets two most important effects of this medication: treatment of inflammatory process and influence tu muscular cells of bronchi. The article reviews in detail the possibility of applying montelukast in allergology as a basis therapy, peculiarities of its pharmacokinetics, pharmacodynamics and safety. Its advantages and disadvantages for monotherapy of bronchial asthma and allergic rhinitis are discussed, as well as the role of this category of medications in combined therapy of bronchial asthma and allergic rhinitis, and its influence to exercise induced bronchoconstriction.Key words: antagonists of leukotriene receptors, montelukast, bronchial asthma, allergic rhinitis, treatment, children. |
| format | Article |
| id | doaj-art-a216d9a6e8c64acd959d607f21d6bcfd |
| institution | Matheson Library |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2006-08-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-a216d9a6e8c64acd959d607f21d6bcfd2025-08-03T19:21:19ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892006-08-01343241575MONTELUKAST IN TREATING ALLERGIC DISEASEST.V. Kulichenko0Scientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowAnti inflammatory medications are the basis for pathogenetic treatment of allergic diseases. The review covers description of the most studied and efficient medication of leukotriene receptors' antagonist category montelukast. Specific and reversible antagonism to leukotriene receptors sets two most important effects of this medication: treatment of inflammatory process and influence tu muscular cells of bronchi. The article reviews in detail the possibility of applying montelukast in allergology as a basis therapy, peculiarities of its pharmacokinetics, pharmacodynamics and safety. Its advantages and disadvantages for monotherapy of bronchial asthma and allergic rhinitis are discussed, as well as the role of this category of medications in combined therapy of bronchial asthma and allergic rhinitis, and its influence to exercise induced bronchoconstriction.Key words: antagonists of leukotriene receptors, montelukast, bronchial asthma, allergic rhinitis, treatment, children.https://www.pedpharma.ru/jour/article/view/579 |
| spellingShingle | T.V. Kulichenko MONTELUKAST IN TREATING ALLERGIC DISEASES Педиатрическая фармакология |
| title | MONTELUKAST IN TREATING ALLERGIC DISEASES |
| title_full | MONTELUKAST IN TREATING ALLERGIC DISEASES |
| title_fullStr | MONTELUKAST IN TREATING ALLERGIC DISEASES |
| title_full_unstemmed | MONTELUKAST IN TREATING ALLERGIC DISEASES |
| title_short | MONTELUKAST IN TREATING ALLERGIC DISEASES |
| title_sort | montelukast in treating allergic diseases |
| url | https://www.pedpharma.ru/jour/article/view/579 |
| work_keys_str_mv | AT tvkulichenko montelukastintreatingallergicdiseases |